/Companies

Cyrano Therateutics

Delray Beach, US · 4 known investors

Find your way into Cyrano Therateutics

Sign up to see every warm intro you have to Cyrano Therateutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cyrano Therateutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.

Founders & leadership

RGRick Geoffrion
Rick GeoffrionFounder, President and CEO & Board Member

Investors · 4

Related companies · 1

Companies working in the same space as Cyrano Therateutics.

Frequently asked questions

What does Cyrano Therateutics do?
Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.
Who founded Cyrano Therateutics?
Cyrano Therateutics was founded by Rick Geoffrion.
Who are Cyrano Therateutics's investors?
Cyrano Therateutics's investors include Remiges Ventures, Inc., DeepWork Capital, Lumira Ventures, Florida Opportunity Fund.
Where is Cyrano Therateutics headquartered?
Cyrano Therateutics is headquartered in Delray Beach, US.